CVAC: CureVac N.V. Ordinary Shares Company Profile & Statistics

About

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

Info & Links

CEO

Alexander Zehnder

Headquarters

Friedrich-Miescher-Strasse 15
T�bingen, 2M 72076, GERMANY

Auditor

EY GmbH & Co. KG Wirtschaftspr�fungsgesellschaft

Share holders

Employees

983

CureVac N.V. Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

1.23B

Enterprise Value

811.47M

Enterprise Value/EBITDA(ttm)

3.47

Price to Earnings Ratio(ttm)

5.96

Price to Sales(ttm)

1.23

Price to Book(mrq)

0.92

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-0.69%

Operating Margin(ttm)

20.72%

Profit Margin(ttm)

-1713.89%

Return on Equity(ttm)

21.98%

Return on Invested Capital(ttm)

13.91%

Return on Assets(ttm)

15.72%

Income Statement

Revenue(ttm)

566.63M

Revenue Per Share(ttm)

Gross Profit(ttm)

496.45M

EBITDA(ttm)³

234.11M

Net Income Available to Common(ttm)

197.23M

Diluted EPS(ttm)

0.55

Share Statistics

Beta (5Y Monthly)

2.51

52-Week Change

69.08%

S&P 500 52-Week Change

9.28%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

219.07M

% Held by Insiders

2.15%

% Held by Institutions

17.26%

Balance Sheet

Total Cash(mrq)

465.74M

Total Cash Per Share(mrq)

Total Debt(mrq)

39.38M

Total Debt/Equity(mrq)

5.78%

Current Ratio(mrq)

7.65%

Quick Ratio(mrq)

6.19%

Book Value Per Share(mrq)

3.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.19

Free Cash Flow(ytd)

-44.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CVAC

CureVac N.V. Ordinary Shares

CureVac N.V. Ordinary Shares Profile